Origin Therapeutics Holdings (XCNQ:ORIG) Pre-Tax Income : C$-2.90 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Origin Therapeutics Holdings's pretax income for the three months ended in Jun. 2023 was C$-0.06 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was C$-2.90 Mil. Origin Therapeutics Holdings's pretax margin was %.

Origin Therapeutics Holdings Pre-Tax Income Historical Data

The historical data trend for Origin Therapeutics Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Pre-Tax Income Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Pre-Tax Income

-1.45

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Pre-Tax Income	Get a 7-Day Free Trial				-0.33	-0.55	-0.13	-2.15	-0.06

Competitive Comparison of Origin Therapeutics Holdings's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Pre-Tax Income falls into.

Origin Therapeutics Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Origin Therapeutics Holdings's Pretax Income for the fiscal year that ended in Sep. 2022 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.017	+	-0.458	+	0	+	0.025	+	0
	=	-1.45

Origin Therapeutics Holdings's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.092	+	-0.001	+	0	+	0.029	+	0
	=	-0.06

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.90 Mil.

Origin Therapeutics Holdings (XCNQ:ORIG) Pre-Tax Income Explanation

Origin Therapeutics Holdings's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.064	/	0
	=	%

Origin Therapeutics Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.